Cargando…
Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris
Plaque psoriasis is a chronic debilitating condition, and biologic agents that inhibit tumor necrosis factor-α (TNF-α) are widely employed in management of the condition. Notwithstanding, several paradoxical adverse reactions have been reported with TNF-α inhibitors, including vasculitis, vitiligo,...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996046/ https://www.ncbi.nlm.nih.gov/pubmed/32038878 http://dx.doi.org/10.1093/omcr/omz134 |